Lexaria Bioscience (LEXX) Short Interest Ratio & Short Volume → Look Who Fired the World’s Richest Man (From Banyan Hill Publishing) (Ad) Free LEXX Stock Alerts $3.19 +0.11 (+3.57%) (As of 02:09 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lexaria Bioscience Short Interest DataCurrent Short Volume257,200 sharesPrevious Short Volume435,600 sharesChange Vs. Previous Month-40.96%Dollar Volume Sold Short$794,748.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares12,890,000 sharesFloat Size11,220,000 sharesShort Percent of Float2.29%Today's Trading Volume47,633 sharesAverage Trading Volume381,334 sharesToday's Volume Vs. Average12% Short Selling Lexaria Bioscience ? Sign up to receive the latest short interest report for Lexaria Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLEXX Short Interest Over TimeLEXX Days to Cover Over TimeLEXX Percentage of Float Shorted Over Time Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic Lexaria Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024257,200 shares $794,748.00 -41.0%2.3%0.5 $3.09 4/15/2024435,600 shares $866,844.00 -11.2%3.7%0.9 $1.99 3/31/2024490,400 shares $1.78 million -35.0%4.3%1.1 $3.63 3/15/2024754,500 shares $2.94 million +13.0%6.5%1.7 $3.90 2/29/2024667,900 shares $2.30 million -2.6%6.4%2.1 $3.45 2/15/2024685,700 shares $1.62 million +15.7%6.6%4 $2.36 Get the Latest News and Ratings for LEXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024592,800 shares $883,272.00 -10.5%6.7%4.5 $1.49 1/15/2024662,400 shares $1.00 million -11.6%7.5%4.8 $1.51 12/31/2023749,200 shares $936,500.00 -3.7%8.6%5.8 $1.25 12/15/2023778,100 shares $988,187.00 +5.9%8.9%6.4 $1.27 11/30/2023734,600 shares $1.10 million +3.2%8.6%6.3 $1.50 11/15/2023712,100 shares $954,214.00 +58.2%8.4%7.2 $1.34 10/31/2023450,000 shares $621,000.00 -2.5%6.2%4.1 $1.38 10/15/2023461,500 shares $422,318.19 +9.1%6.4%5.2 $0.92 9/30/2023422,900 shares $422,857.71 +14.5%5.8%4.9 $1.00 9/15/2023369,200 shares $321,573.20 -14.5%5.6%4.2 $0.87 8/31/2023431,900 shares $453,451.81 +0.2%6.2%4.5 $1.05 8/15/2023431,000 shares $478,410.00 +44.9%5.8%3.5 $1.11 7/31/2023297,500 shares $247,966.25 +3.3%4.0%1.6 $0.83 7/15/2023288,100 shares $238,460.37 +4.5%3.9%1.6 $0.83 6/30/2023275,700 shares $201,343.71 -11.0%3.7%1.8 $0.73 6/15/2023309,800 shares $213,823.96 -9.7%4.2%2.1 $0.69 5/31/2023343,000 shares $254,780.40 +31.9%4.7%2.5 $0.74 5/15/2023260,100 shares $188,520.48 -14.4%3.6%1.9 $0.72 4/30/2023303,800 shares $634,942.00 -4.4%5.7%6.5 $2.09 4/15/2023317,900 shares $693,022.00 -6.1%5.9%15.3 $2.18 3/31/2023338,500 shares $920,720.00 +4.2%6.3%16.1 $2.72 3/15/2023325,000 shares $880,750.00 -0.7%6.7%16 $2.71 2/28/2023327,300 shares $991,719.00 +3.8%6.8%16.6 $3.03 2/15/2023315,200 shares $936,207.04 +5.3%6.5%19.5 $2.97 1/31/2023299,400 shares $961,103.94 +9.5%6.2%19.6 $3.21 1/15/2023273,400 shares $757,318.00 +0.0%5.6%18.1 $2.77 12/30/2022273,300 shares $672,318.00 -2.2%5.1%17.2 $2.46 12/15/2022279,300 shares $779,219.07 -8.5%5.2%14.5 $2.79 11/30/2022305,200 shares $903,392.00 -0.6%5.7%13.4 $2.96 11/15/2022307,100 shares $738,575.50 -5.1%5.8%12.8 $2.41 10/31/2022323,600 shares $715,156.00 +3.2%6.1%8.9 $2.21 10/15/2022313,500 shares $661,485.00 -5.2%5.9%8.1 $2.11 9/30/2022330,600 shares $809,970.00 +1.2%6.2%8 $2.45 9/15/2022326,700 shares $957,231.00 -2.3%6.1%6.2 $2.93Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic LEXX Short Interest - Frequently Asked Questions What is Lexaria Bioscience's current short interest? Short interest is the volume of Lexaria Bioscience shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 257,200 shares of LEXX short. 2.29% of Lexaria Bioscience's shares are currently sold short. Learn More on Lexaria Bioscience's current short interest. What is a good short interest percentage for Lexaria Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.29% of Lexaria Bioscience's floating shares are currently sold short. Is Lexaria Bioscience's short interest increasing or decreasing? Lexaria Bioscience saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 257,200 shares, a drop of 41.0% from the previous total of 435,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lexaria Bioscience's float size? Lexaria Bioscience currently has issued a total of 12,890,000 shares. Some of Lexaria Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lexaria Bioscience currently has a public float of 11,220,000 shares. How does Lexaria Bioscience's short interest compare to its competitors? 2.29% of Lexaria Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lexaria Bioscience: Cara Therapeutics, Inc. (5.62%), Xilio Therapeutics, Inc. (5.24%), Unicycive Therapeutics, Inc. (2.13%), Sensei Biotherapeutics, Inc. (0.37%), VYNE Therapeutics Inc. (0.68%), CASI Pharmaceuticals, Inc. (0.73%), Eyenovia, Inc. (12.11%), Gain Therapeutics, Inc. (1.02%), ProMIS Neurosciences, Inc. (0.05%), Marker Therapeutics, Inc. (0.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lexaria Bioscience stock? Short selling LEXX is an investing strategy that aims to generate trading profit from Lexaria Bioscience as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexaria Bioscience? A short squeeze for Lexaria Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEXX, which in turn drives the price of the stock up even further. How often is Lexaria Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEXX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Cara Therapeutics Short Squeeze Xilio Therapeutics Short Squeeze Unicycive Therapeutics Short Squeeze Sensei Biotherapeutics Short Squeeze VYNE Therapeutics Short Squeeze CASI Pharmaceuticals Short Squeeze Eyenovia Short Squeeze Gain Therapeutics Short Squeeze ProMIS Neurosciences Short Squeeze Marker Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LEXX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold